Skip to main content
. 2020 Dec 9;57(2):106260. doi: 10.1016/j.ijantimicag.2020.106260

Table 1.

Clinical characteristics of newborns of SARS-CoV-2-infected pregnant women

Clinical characteristics
Birthday Bodyweight (kg) Apgar score (1 min, 5 min) Inpatient days Gestational age on infection Gestational age on admission Complications SARS-CoV-2 nucleic acid assay CT detection
Fetus 1 Mar, 5 2.70 8, 9 16 32W 38W Anemia, Hyperbilirubinemia Negative Infection on lungs
Fetus 2 Mar, 4 3.10 8, 9 18 38W 38W NA Negative Infection on lungs
Fetus 3 Feb, 16 1.58 8, 9 30 30W+5 31W Anemia, Hyperbilirubinemia Negative
Fetus 4 Feb, 15 2.92 8, 9 25 37W+5 38W+3 Hyperbilirubinemia Negative
Fetus 5 Feb, 13 2.84 8, 9 32 34w 36w+3 Hyperbilirubinemia Negative
Fetus 6 Feb, 16 3.29 8, 9 36 36W+1 39W+1 NA Negative
Fetus 7 Mar, 4 1.06 7, 8 55 26W+6 28W+5 Hyperbilirubinemia Negative Infection on lungs
Fetus 8 Feb, 20 4.12 8, 9 16 41W+1 41W+2 Hyperbilirubinemia Negative
Fetus 9 Mar, 17 3.10 8, 9 45 30W 38W+2 Hyperbilirubinemia Negative
Fetus 10 Feb, 14 2.58 8, 9 34 35W+1 35W+2 NA Negative
Fetus 11 Feb, 27 3.86 8, 10 13 34W+3 38W Hyperbilirubinemia Negative
Fetus 12 Feb, 29 3.93 8, 9 14 34W+6 39W Hyperbilirubinemia Negative
Fetus 13 Feb, 21 3.17 8, 9 15 38W+2 39W Hyperbilirubinemia Negative
Fetus 14 Mar, 19 2.58 8, 9 9 35W+3 35W+6 Hyperbilirubinemia Negative
Fetus 15 Mar, 19 2.29 8, 10 6 35W+3 35W+6 Hyperbilirubinemia Negative
Fetus 16 Mar, 18 3.14 8, 9 16 31W+3 38W Hyperbilirubinemia Negative
Fetus 17 Feb, 17 2.64 8, 9 14 37W+4 37W+5 Hyperbilirubinemia Negative
Fetus 18 Feb, 20 3.71 9, 10 10 38W+3 38W+6 NA Negative
Fetus 19 Apr, 17 3.05 8, 9 5 38W+2 38W+3 Hyperbilirubinemia Negative
Fetus 20 Apr, 6 2.75 9, 10 16 39W+4 39W+5 Hyperbilirubinemia Negative
Fetus 21 Apr, 3 3.60 9, 10 2 39W+6 40W Hyperbilirubinemia Negative
Fetus 22 Apr, 18 3.55 8, 10 14 38W+2 38W+3 NA Negative

NA: no complications; —: not tested